Published in:

Open Access 01-12-2010 | Oral presentation

Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment-naïve, HIV-1-infected patients

Authors: C Cohen, JM Molina, P Cahn, B Clotet, J Fourie, B Grinsztejn, W Hao, M Johnson, K Supparatpinyo, HM Crauwels, L Rimsky, S Vanveggel, P Williams, K Boven

Published in: Journal of the International AIDS Society | Special Issue 4/2010